ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

Men’s Health Month is a time dedicated to raising awareness around preventable health conditions and encouraging men to prioritize routine care and early detection. A new, FDA-approved blood test is m ...

CancerCare Manitoba is encouraging more Manitobans to take part in routine colorectal cancer screening, particularly in ...